Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimmich

Showing results (251-260 of 331) with videos related to

Pageof 34
Sort By:
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2021
Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual diseaseBernd Metzner, Jutta Welzel, Thomas H Müller, et al.
European Journal of Haematology|July 21, 2021
Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Christiane Pott, Thomas H Müller, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2018
[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example]F Griesinger, S Radke, A Lüers, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 11, 2013
The endophenotype and the phenotype: temporal discrimination and adult-onset dystoniaMichael Hutchinson, Okka Kimmich, Anna Molloy, et al.
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Blood|June 4, 2016
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up studyTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Haematologica|January 19, 2019
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmiaTobias Dittrich, Axel Benner, Christoph Kimmich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 1, 2014
Temporal discrimination, a cervical dystonia endophenotype: penetrance and functional correlatesOkka Kimmich, Anna Molloy, Robert Whelan, et al.
Pageof 34

Showing results (251-260 of 331) with videos related to

Sort By:
Pageof 34
Cancers|July 24, 2021
Antibiotic Prophylaxis or Granulocyte-Colony Stimulating Factor Support in Multiple Myeloma Patients Undergoing Autologous Stem Cell TransplantationEva-Maria Klein, Sandra Sauer, Sabrina Klein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 4, 2021
Long-term remissions in patients with early relapse of diffuse large B-cell lymphoma following high-dose chemotherapy, autologous stem cell transplantation, and radiotherapy of residual diseaseBernd Metzner, Jutta Welzel, Thomas H Müller, et al.
European Journal of Haematology|July 21, 2021
Long-term outcome in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationBernd Metzner, Christiane Pott, Thomas H Müller, et al.
Pneumologie (Stuttgart, Germany)|November 9, 2018
[Strategies to Overcome Acquired Resistance to EGFR-TKI Therapy Based on T790M Specific Substances using Osimertinib as an Example]F Griesinger, S Radke, A Lüers, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 26, 2020
Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patientsPaolo Milani, Faye Sharpley, Stefan O Schönland, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 11, 2013
The endophenotype and the phenotype: temporal discrimination and adult-onset dystoniaMichael Hutchinson, Okka Kimmich, Anna Molloy, et al.
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Blood|June 4, 2016
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up studyTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Haematologica|January 19, 2019
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmiaTobias Dittrich, Axel Benner, Christoph Kimmich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 1, 2014
Temporal discrimination, a cervical dystonia endophenotype: penetrance and functional correlatesOkka Kimmich, Anna Molloy, Robert Whelan, et al.
Pageof 34